| scholarly article | Q13442814 |
| P50 | author | Nikolaos G Frangogiannis | Q56899107 |
| P2093 | author name string | Wei Chen | |
| Marcin Dobaczewski | |||
| P2860 | cites work | Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways | Q24296716 |
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium | Q24679838 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology | Q28138090 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Making sense of latent TGFbeta activation | Q28217641 | ||
| New insights into TGF-beta-Smad signalling | Q28260517 | ||
| Regulation of immune responses by TGF-beta | Q28271433 | ||
| Differential protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy | Q28564253 | ||
| Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo | Q28568955 | ||
| Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload | Q28575610 | ||
| Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype | Q28581981 | ||
| Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
| TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes | Q28592444 | ||
| Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice | Q28594495 | ||
| Specificity and versatility in tgf-beta signaling through Smads | Q29616324 | ||
| How cells read TGF-beta signals | Q29619993 | ||
| TGF-beta signaling and the fibrotic response | Q29620099 | ||
| Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis | Q33521188 | ||
| Proteolytic control of growth factor availability | Q33586464 | ||
| Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart | Q33656046 | ||
| The role of inflammatory and fibrogenic pathways in heart failure associated with aging. | Q34061245 | ||
| TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses | Q34089674 | ||
| Transforming growth factor-beta activation in irradiated murine mammary gland | Q34128453 | ||
| Latency, activation, and binding proteins of TGF-beta | Q34136471 | ||
| Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes | Q34243039 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| Transforming growth factor-beta 1 bifunctionally regulates murine macrophage proliferation | Q68054468 | ||
| Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms | Q73035986 | ||
| Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro | Q73212518 | ||
| Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription | Q73280041 | ||
| Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts | Q73542345 | ||
| Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart | Q73556354 | ||
| Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice | Q73561264 | ||
| Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy | Q73606421 | ||
| Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats | Q74162665 | ||
| Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats | Q74397793 | ||
| Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart | Q77299992 | ||
| Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio | Q77822656 | ||
| Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction | Q80987635 | ||
| Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts | Q81802458 | ||
| Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. | Q35083426 | ||
| TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing | Q35841836 | ||
| TGF-beta1 and angiotensin networking in cardiac remodeling | Q35846911 | ||
| Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction | Q35947836 | ||
| TGF-beta receptor function in the endothelium. | Q36017194 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| Transforming growth factor-beta: a key mediator of fibrosis | Q36239091 | ||
| Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. | Q36249250 | ||
| Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
| Beta transforming growth factors are potential regulators of B lymphopoiesis | Q36357527 | ||
| The role of TGF-beta signaling in myocardial infarction and cardiac remodeling | Q36655326 | ||
| Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets | Q37130706 | ||
| TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. | Q37339703 | ||
| Transforming growth factor-beta 3 is required for secondary palate fusion | Q37373842 | ||
| Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor | Q37412421 | ||
| Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. | Q37434655 | ||
| Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis | Q37591872 | ||
| Thrombospondins in the heart: potential functions in cardiac remodeling | Q37607128 | ||
| Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation | Q37764239 | ||
| Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors | Q39646992 | ||
| TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. | Q39737677 | ||
| A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats | Q39914658 | ||
| Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction | Q40543293 | ||
| Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta 1. | Q41098186 | ||
| Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity | Q41489951 | ||
| Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction | Q41769718 | ||
| Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats | Q42098308 | ||
| Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patients | Q43062936 | ||
| Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction | Q43162631 | ||
| Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction | Q43754711 | ||
| Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
| Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). | Q44103977 | ||
| Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction | Q44528242 | ||
| Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure | Q45883186 | ||
| Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts | Q46061333 | ||
| Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway | Q47942744 | ||
| Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support. | Q51833940 | ||
| Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. | Q52583103 | ||
| Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. | Q52965082 | ||
| TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. | Q64979026 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 600-606 | |
| P577 | publication date | 2010-11-06 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Transforming growth factor (TGF)-β signaling in cardiac remodeling | |
| P478 | volume | 51 |
| Q90668227 | A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse |
| Q64061821 | A Multi-Trait Approach Identified Genetic Variants Including a Rare Mutation in RGS3 with Impact on Abnormalities of Cardiac Structure/Function |
| Q57162280 | A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure |
| Q38173671 | A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling |
| Q58802404 | AAV9-mediated Rbm24 overexpression induces fibrosis in the mouse heart |
| Q38698086 | AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation. |
| Q60921233 | AMPK: a therapeutic target of heart failure-not only metabolism regulation |
| Q91025226 | Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells |
| Q64233349 | Acetazolamide attenuates cardiac fibrosis induced by aortic constriction through inhibiting transforming growth factor-β1/Smad2 signaling pathway in mice |
| Q55078015 | Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling. |
| Q34258422 | Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway |
| Q33684123 | Adult murine cardiomyocytes exhibit regenerative activity with cell cycle reentry through STAT3 in the healing process of myocarditis. |
| Q64967935 | Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies. |
| Q35155965 | Aging and Cardiac Fibrosis. |
| Q37096257 | Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling |
| Q84096219 | Alterations in cardiac structure and function in a murine model of chronic alcohol consumption |
| Q55469020 | Ambient fine particulate matter exposure induces reversible cardiac dysfunction and fibrosis in juvenile and older female mice. |
| Q35916617 | Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode |
| Q90002660 | An Improved Method of Maintaining Primary Murine Cardiac Fibroblasts in Two-Dimensional Cell Culture |
| Q94453352 | Analysis of gene expression profiling of amyloidogenic immunoglobulin light-chains on cultured rat cardiomyocytes |
| Q55026390 | Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation. |
| Q34256551 | Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β. |
| Q89684513 | Angiotensin II blockade had no effect on range of motion after total knee arthroplasty: a retrospective review |
| Q54551007 | Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. |
| Q64084644 | Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis |
| Q33604328 | Association of the common genetic polymorphisms and haplotypes of the chymase gene with left ventricular mass in male patients with symptomatic aortic stenosis |
| Q37082373 | Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study |
| Q51010460 | Astaxanthin Prevented Oxidative Stress in Heart and Kidneys of Isoproterenol-Administered Aged Rats. |
| Q37590158 | Atrial fibrillation: mechanisms, therapeutics, and future directions |
| Q36819566 | Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts |
| Q35274466 | Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts |
| Q41255959 | BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure |
| Q42811847 | BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery. |
| Q35924740 | BMSCs Interactions with Adventitial Fibroblasts Display Smooth Muscle Cell Lineage Potential in Differentiation and Migration That Contributes to Neointimal Formation |
| Q34520504 | Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation |
| Q89482746 | Biomarkers for the identification of cardiac fibroblast and myofibroblast cells |
| Q92557859 | Biowire Model of Interstitial and Focal Cardiac Fibrosis |
| Q53511596 | C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. |
| Q92895225 | C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts |
| Q90550496 | CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice |
| Q92740403 | CRISPR-Knockout Screen Identifies Dmap1 as a Regulator of Chemically Induced Reprogramming and Differentiation of Cardiac Progenitors |
| Q44454656 | Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome |
| Q92309063 | Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players |
| Q92752512 | Cardiac Fibroblasts and the Extracellular Matrix in Regenerative and Nonregenerative Hearts |
| Q58121824 | Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF -β Signaling |
| Q38423895 | Cardiac fibroblast physiology and pathology |
| Q28068468 | Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration |
| Q58757982 | Cardiac fibrosis: new insights into the pathogenesis |
| Q35086438 | Cardiac steatosis potentiates angiotensin II effects in the heart |
| Q53657028 | Cardiac stem cells transplantation enhances the expression of connexin 43 via the ANG II/AT1R/TGF-beta1 signaling pathway in a rat model of myocardial infarction. |
| Q36109025 | Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice. |
| Q52691424 | Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice. |
| Q51129708 | Cardioprotective effects of pectin-insulin patch in streptozotocin-induced diabetic rats. |
| Q41333298 | Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction |
| Q38811208 | Cellular recruitment in myocardial ischaemia/reperfusion injury. |
| Q88962093 | Characterization of fibroblasts from hypertrophied right ventricle of pulmonary hypertensive rats |
| Q90450529 | Circulating extracellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome |
| Q57477200 | Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study |
| Q35140603 | Circulating serum markers and QRS scar score in Chagas cardiomyopathy |
| Q49532380 | Collagenolytic Activity Is Associated with Scar Resolution in Zebrafish Hearts after Cryoinjury |
| Q90745514 | Combinatorial Treatment of Human Cardiac Engineered Tissues With Biomimetic Cues Induces Functional Maturation as Revealed by Optical Mapping of Action Potentials and Calcium Transients |
| Q36917391 | Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis |
| Q36786619 | Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells |
| Q43507186 | Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human. |
| Q52633077 | Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis. |
| Q35588665 | Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins |
| Q93110989 | Co‑culturing with hypoxia pre‑conditioned mesenchymal stem cells as a new strategy for the prevention of irradiation‑induced fibroblast‑to‑myofibroblast transition |
| Q28547428 | Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads Signalings |
| Q34295008 | Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation |
| Q47713533 | Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth |
| Q37209512 | Cytokine mediated tissue fibrosis |
| Q36329742 | Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts |
| Q90482274 | Determination of the Th1, Th2, Th17, and Treg cytokine profile in patients with chronic Chagas heart disease and systemic arterial hypertension |
| Q38698647 | Detrimental role of lysyl oxidase in cardiac remodeling. |
| Q36737035 | Developments in the management of Chagas cardiomyopathy |
| Q36479405 | Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities |
| Q37658195 | Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis |
| Q64898891 | Directional Topography Influences Adipose Mesenchymal Stromal Cell Plasticity: Prospects for Tissue Engineering and Fibrosis. |
| Q35893732 | Dual Endothelin Receptor Blockade Abrogates Right Ventricular Remodeling and Biventricular Fibrosis in Isolated Elevated Right Ventricular Afterload |
| Q47685050 | Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity |
| Q37367994 | ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene |
| Q52670776 | Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding. |
| Q92798645 | Effects of losartan and atorvastatin on the development of early posttraumatic joint stiffness in a rat model |
| Q84755827 | Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling |
| Q36322805 | Emerging role of liver X receptors in cardiac pathophysiology and heart failure |
| Q34602939 | Enhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis |
| Q31095420 | Establishment of a prediction model of changing trends in cardiac hypertrophy disease based on microarray data screening |
| Q92106303 | Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction |
| Q42379105 | Estrogen deprivation aggravates cardiac hypertrophy in nonobese Type 2 diabetic Goto-Kakizaki (GK) rats |
| Q34891653 | Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling |
| Q91142496 | Evolving concepts in the pathogenesis of uraemic cardiomyopathy |
| Q58730304 | Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions |
| Q96683630 | Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p |
| Q33877795 | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction |
| Q35627274 | Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling |
| Q58571180 | Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts |
| Q47094281 | Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis |
| Q37716851 | Fibroblasts in myocardial infarction: a role in inflammation and repair |
| Q36522008 | Fibroblasts in post-infarction inflammation and cardiac repair. |
| Q50098773 | Fibrosis-Related Gene Expression in Single Ventricle Heart Disease |
| Q34076151 | Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study |
| Q37037402 | Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β. |
| Q40328847 | Fibulin-6 regulates pro-fibrotic TGF-β responses in neonatal mouse ventricular cardiac fibroblasts |
| Q38085345 | Function and fate of myofibroblasts after myocardial infarction |
| Q38431067 | Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation |
| Q45861410 | Gene Therapy in Heart Failure |
| Q37726526 | Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain |
| Q34340857 | Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine |
| Q36497170 | Genetic mutations and mechanisms in dilated cardiomyopathy |
| Q36342172 | Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice |
| Q37398045 | Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy |
| Q26863465 | Good and bad sides of TGFβ-signaling in myocardial infarction |
| Q89964430 | Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes |
| Q38269044 | Heart failure and galectin 3. |
| Q37633991 | Heart failure with preserved ejection fraction in the elderly: scope of the problem |
| Q33889242 | Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium |
| Q47152288 | Heat Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy |
| Q42134741 | Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression |
| Q37710008 | Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3. |
| Q51715559 | How could analyzing the activity of two matrix metalloproteinases unveil the cause of sudden cardiac death. |
| Q93083874 | Hsa-miR-335 regulates cardiac mesoderm and progenitor cell differentiation |
| Q94475752 | Human umbilical cord blood cells rescued traumatic brain injury-induced cardiac and neurological deficits |
| Q49333970 | Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways |
| Q42347141 | Hydrogen-containing saline alleviates pressure overload-induced interstitial fibrosis and cardiac dysfunction in rats |
| Q38312860 | Hypoxia activates muscle-restricted coiled-coil protein (MURC) expression via transforming growth factor-β in cardiac myocytes |
| Q43084246 | IPW-5371 Proves Effective as a Radiation Countermeasure by Mitigating Radiation-Induced Late Effects |
| Q98169869 | Identifying the key regulators that promote cell-cycle activity in the hearts of early neonatal pigs after myocardial injury |
| Q42180878 | In search of novel targets for heart disease: myocardin and myocardin-related transcriptional cofactors |
| Q91644915 | In vivo and in vitro Approaches Reveal Novel Insight Into the Ability of Epicardium-Derived Cells to Create Their Own Extracellular Environment |
| Q41752395 | Increased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor-Deficient Mice |
| Q41739115 | Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy. |
| Q91107167 | Increased myocardial stiffness activates cardiac microvascular endothelial cell via VEGF paracrine signaling in cardiac hypertrophy |
| Q38390454 | Inflammation in cardiac injury, repair and regeneration. |
| Q91980987 | Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis |
| Q35177115 | Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism |
| Q90595663 | Initial Changes in the Heart Conduction System Illustrated by Difference Map Patterns in Adolescent Patients After Kidney Transplantation: A Pilot Study |
| Q33648136 | Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction |
| Q38566665 | Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts |
| Q47969185 | Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium |
| Q38042490 | Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing |
| Q34707131 | Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation. |
| Q43904053 | Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice |
| Q36891606 | Left and right ventricle late remodeling following myocardial infarction in rats. |
| Q64071710 | LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation |
| Q92494633 | Long non-coding RNA RNF7 promotes the cardiac fibrosis in rat model via miR-543/THBS1 axis and TGFβ1 activation |
| Q64075434 | Long-term impact of maternal high-fat diet on offspring cardiac health: role of micro-RNA biogenesis |
| Q64084650 | Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing |
| Q35542423 | Matricellular proteins in cardiac adaptation and disease |
| Q36184322 | Matrix-dependent perturbation of TGFβ signaling and disease |
| Q38653648 | Mechanical control of cardiac myofibroblasts |
| Q50066226 | Mechanisms of Fibroblast Activation in the Remodeling Myocardium |
| Q93099741 | Mechanisms of cardiac collagen deposition in experimental models and human disease |
| Q37652827 | Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload |
| Q39297520 | Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells |
| Q92093456 | Mesenchymal-endothelial transition-derived cells as a potential new regulatory target for cardiac hypertrophy |
| Q89180768 | Metabolic Coordination of Physiological and Pathological Cardiac Remodeling |
| Q38641091 | MiR-30e attenuates isoproterenol-induced cardiac fibrosis through suppressing Snai1/TGFβ signaling |
| Q38286294 | MiRNAs as potential molecular targets in heart failure |
| Q28118775 | MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4 |
| Q36723373 | Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression |
| Q64243195 | Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells |
| Q40362636 | Modulation of angiotensin II signaling in the prevention of fibrosis |
| Q42149657 | Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation |
| Q90348644 | Molecular determinants of mesenchymal cell activation in fibroproliferative diseases |
| Q37914058 | Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. |
| Q40071887 | Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1. |
| Q91393765 | Multipoint targeting of TGF-β/Wnt transactivation circuit with microRNA 384-5p for cardiac fibrosis |
| Q92688761 | Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart |
| Q36885706 | Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. |
| Q42058494 | Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence |
| Q37972978 | Myofibroblasts in the infarct area: concepts and challenges |
| Q89531776 | Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis |
| Q53173170 | Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease. |
| Q64235114 | Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts |
| Q26825697 | Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities |
| Q64137534 | Osthole decreases collagen I/III contents and their ratio in TGF-β1-overexpressed mouse cardiac fibroblasts through regulating the TGF-β/Smad signaling pathway |
| Q36850768 | Pasteurella multocida toxin (PMT) upregulates CTGF which leads to mTORC1 activation in Swiss 3T3 cells |
| Q58091796 | Pathological cardiac remodeling occurs early in CKD mice from unilateral urinary obstruction, and is attenuated by Enalapril |
| Q35127231 | Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration |
| Q90353758 | Pim1 Maintains Telomere Length in Mouse Cardiomyocytes by Inhibiting TGFβ Signaling |
| Q33603596 | Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways |
| Q27318048 | Pitx2c is reactivated in the failing myocardium and stimulates myf5 expression in cultured cardiomyocytes |
| Q36583294 | Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. |
| Q37354306 | Plasma proANP and SDMA and microRNAs are associated with chronic mitral regurgitation in a pig model |
| Q45868567 | Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis |
| Q42273281 | Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation. |
| Q53565583 | Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients. |
| Q37071136 | Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation |
| Q26865949 | Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review |
| Q38316469 | Post-myocardial infarct inflammation and the potential role of cell therapy |
| Q35723587 | Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring |
| Q64063810 | Protective effect of some natural products against chemotherapy-induced toxicity in rats |
| Q33790719 | Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition. |
| Q64092700 | Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats |
| Q90185168 | RUNX1: an emerging therapeutic target for cardiovascular disease |
| Q49679389 | RV pressure overload: from hypertrophy to failure. |
| Q44096043 | Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis |
| Q53052642 | Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1. |
| Q42375617 | Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target |
| Q38190443 | Regulatory RNAs and paracrine networks in the heart. |
| Q38853917 | Relationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction. |
| Q88968512 | Role of cytokines and inflammation in heart function during health and disease |
| Q33755691 | SHSST cyclodextrin complex prevents the fibrosis effect on CCl₄-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects |
| Q38859940 | SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis |
| Q35071386 | Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy |
| Q34211886 | Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta |
| Q35095828 | Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease |
| Q93025612 | Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro- and Microvascular Disease |
| Q61799680 | Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease |
| Q95661032 | Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation |
| Q35005754 | Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. |
| Q57490976 | Sodium Houttuyfonate Alleviates Post-infarct Remodeling in Rats via AMP-Activated Protein Kinase Pathway |
| Q38667881 | Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodeling in mice through TGF-β1/Smad3 pathway. |
| Q45953214 | Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy. |
| Q85522346 | Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress |
| Q38842278 | Syndecans in heart fibrosis |
| Q92644753 | Synergistic effect of estradiol and testosterone protects against IL-6-inducedcardiomyocyte apoptosismediated by TGF-β1 |
| Q47152878 | Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy |
| Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
| Q47369105 | T cell subsets: an integral component in pathogenesis of rheumatic heart disease |
| Q58794179 | TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
| Q92311732 | TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease |
| Q37899212 | TGF-β signaling in fibrosis |
| Q53508778 | TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease. |
| Q64279254 | TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease |
| Q35805680 | TSC-22 up-regulates collagen 3a1 gene expression in the rat heart |
| Q37100838 | Targeting inflammatory pathways in myocardial infarction. |
| Q38120799 | Targeting the chemokines in cardiac repair. |
| Q42590775 | Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils |
| Q36912426 | Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q90765693 | The ATRQβ-001 vaccine improves cardiac function and prevents postinfarction cardiac remodeling in mice |
| Q38875774 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. |
| Q52562680 | The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice. |
| Q38675294 | The Janus face of myofibroblasts in the remodeling heart |
| Q34071933 | The Notch pathway controls fibrotic and regenerative repair in the adult heart |
| Q42694416 | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis |
| Q26744761 | The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension |
| Q48220874 | The Role of c-SKI in Regulation of TGFβ-Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression |
| Q33737254 | The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart |
| Q38044657 | The TGF-β pathway as an emerging target for Chagas disease therapy. |
| Q92654748 | The aqueous extract of Gentianella acuta improves isoproterenol‑induced myocardial fibrosis via inhibition of the TGF‑β1/Smads signaling pathway |
| Q89629055 | The association between microRNA-21 and hypertension-induced cardiac remodeling |
| Q90104612 | The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human |
| Q33721878 | The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy |
| Q35125156 | The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy |
| Q38407430 | The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens |
| Q37341800 | The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations |
| Q38144845 | The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. |
| Q35529656 | The inflammatory response in myocardial injury, repair, and remodelling. |
| Q53615353 | The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects. |
| Q34807853 | The overexpression of Twinkle helicase ameliorates the progression of cardiac fibrosis and heart failure in pressure overload model in mice |
| Q37161329 | The pathogenesis of cardiac fibrosis. |
| Q27002949 | The physiology of cardiovascular disease and innovative liposomal platforms for therapy |
| Q92453964 | The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients |
| Q35065245 | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. |
| Q38023271 | The role of TWEAK/Fn14 in cardiac remodeling |
| Q38034004 | The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction |
| Q39265526 | The role of transforming growth factor (TGF)-β in the infarcted myocardium |
| Q53124136 | The transcardiac gradient of cardio-microRNAs in the failing heart. |
| Q55289622 | Therapeutic Potential of Polyphenols in Cardiac Fibrosis. |
| Q90643368 | Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling |
| Q35534242 | Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation |
| Q54785371 | Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling. |
| Q35923510 | Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways |
| Q87224605 | Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling |
| Q48728454 | Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3. |
| Q42247071 | Transforming growth factor β and its role in heart disease |
| Q34089713 | Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction |
| Q36549555 | Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease |
| Q96817489 | Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78) |
| Q91971971 | Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433 |
| Q50201254 | Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis. |
| Q84788582 | Where are the new drugs to treat heart failure? Introduction to the special issue on "key signaling molecules in hypertrophy and heart failure" |
| Q92860289 | Zebrafish as a Smart Model to Understand Regeneration After Heart Injury: How Fish Could Help Humans |
| Q89938818 | miR-1-5p targets TGF-βR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension |
| Q57823449 | miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy |
| Q39413020 | miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling |
| Q90255266 | βIV-Spectrin/STAT3 complex regulates fibroblast phenotype, fibrosis, and cardiac function |
Search more.